About Us

Optimizing Fluid Management and Acute Renal Care

Measurement of urine output is recognized as a key indicator of a patient's fluid balance and kidney function, particularly in the critical care environment. Kidney injury occurs in approximately 30% of critical care patients and results in greater costs of care and higher mortality rates. Today, urine output is measured either by urine bags or mechanical urine meters which are labor intensive, inaccurate, and which do not provide current data.

Medical professionals recognize the impact that reliable, real-time, continuous urine output monitoring can have on patient care.

FlowSense's URINFO2000 enables real-time, continuous monitoring of urine output for the optimization of fluid management and acute renal care. The product provides clinicians with an early and on-going assessment of fluid balance and renal condition which can improve patient outcomes and reduce hospital costs.

FlowSense was founded in 2009 by The Trendlines Group and is led by a strong management team experienced in the successful growth of medical device companies.  The company's product is currently in use in critical care units.